Form 4: Zimmer Biomet Director Christopher Begley Reports Acquisition of Phantom Stock Units

Director Christopher Begley reports acquisition of phantom stock units under Zimmer Biomet's deferred compensation plan.

Summary

• Christopher B. Begley, a director of Zimmer Biomet Holdings, Inc., reported the acquisition of phantom stock units on December 31, 2024.
• The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• A total of 567.483 phantom stock units were acquired at a price of $105.73 per unit.
• These units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.
• Following the transaction, Begley beneficially owns 21,358.958 phantom stock units.
• This amount includes 46.037 phantom stock units accrued on October 31, 2024, under the dividend reinvestment provision of the plan.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard compensation practices and director's continued investment in the company.

Positives

• The acquisition of phantom stock units demonstrates the director's continued investment in the company's future.
• The deferred compensation plan aligns the interests of non-employee directors with those of shareholders.

Future Outlook

The phantom stock units will be settled in cash within sixty days after cessation of the reporting person's service as a Director.

Industry Context

This filing is a routine disclosure related to director compensation and is typical for publicly traded companies.

Stakeholder Impact

• The acquisition of phantom stock units aligns the director's interests with those of the shareholders.

Key Dates